(NASDAQ:TMC), Following successful mining tests by U.S. consortia and pioneering environmental impact assessment by the National Oceanic and Atmospheric Administration (NOAA) in the Clarion Clipperton Zone (CCZ) in the 1970s, the United States Congress passed the Deep Seabed Hard Mineral Resources Act (DSHMRA) in 1980 to enable exploration and commercial recovery of deep-sea minerals in […]

(NasdaqGM:FEIM),(NYSE:LDOS), MITCHEL FIELD, N.Y., March 27, 2025 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency technology, today announced it has been awarded a subcontract from Leidos (NYSE: LDOS) to develop a next-generation Nitrogen Vacancy (NV) Diamond Magnetometer. The award supports the development of a

(NASDAQ:CACC), Southfield, Michigan, March 27, 2025 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today the completion of a $400.0 million asset-backed non-recourse secured financing (the “Financing”). Pursuant to this transaction, we conveyed loans having a value of approximately $500.2 million to a wholly owned special

(NasdaqGM:TPIC), SCOTTSDALE, Ariz., March 27, 2025 (GLOBE NEWSWIRE) — TPI Composites, Inc. (Nasdaq: TPIC), today published its 2024 sustainability report highlighting its progress on organizational and global impacts related to sustainability. Bill Siwek, President, and CEO noted, “We remain committed to helping the world increase renewable energy production. As we advance our goals and strategy

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth quarter and full year ended December 31, 2024. “In September of 2024 we hosted an Investor R&D Day in New York,” said Victor Perlroth, M.D., Chief Executive Officer of Kodiak Sciences. “The Investor R&D Day webcast and presentation featured

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the fourth quarter and full year ended December 31, 2024. https://mma.prnewswire.com/media/1856437/Co_Diagnostics_New_Logo_v1.jpg Full Year 2024 Financial Results: — Revenue of $3.9 million, which declined from $6.8 million during the prior year

Full Year Revenue of $62.3 Million In-Line with Revised Revenue Guidance Continued to Diversify Customer Base with Leading Sell-Side Partners and Buy-Side Customers in New Verticals Management to Host Conference Call at 5:00 PM ET Today Direct Digital Holdings, Inc. (Nasdaq: DRCT) (“Direct Digital Holdings” or the “Company”), a leading advertising and marketing technology platform

(NASDAQ:BEAM), U.S. IND Represents Regulatory Clearance For BEAM-302 Spanning Six Countries and Second Open IND for a Beam In Vivo Base Editing Program in the U.S. CAMBRIDGE, Mass., March 27, 2025 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States

(NASDAQ:SPRO), Pre-specified interim analysis of Phase 3 PIVOT-PO clinical trial of tebipenem HBr in complicated urinary tract infection (cUTI) is expected to be completed in Q2 2025 Company expects to complete analysis of full data set from the Phase 2 study of SPR720 for treatment of Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) and determine next steps

(NASDAQ:GEVO), ENGLEWOOD, Colo., March 27, 2025 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”), a leading developer of cost effective, renewable hydrocarbon fuels and chemicals with reduced greenhouse gas emissions, today announced financial results for the fourth quarter and full year ended December 31, 2024, and reaffirmed the Business